ロード中...
Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds
BACKGROUND: Determining the cost-effectiveness thresholds for healthcare interventions has been a severe challenge for policymakers, especially in low- and middle-income countries. This study aimed to estimate the cost per disability-adjusted life-year (DALY) averted for countries with different lev...
保存先:
| 出版年: | Cost Eff Resour Alloc |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7863358/ https://ncbi.nlm.nih.gov/pubmed/33541364 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12962-021-00260-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|